| Serial Number | 79155885 |
| Word Mark | AFFILIN |
| Filing Date | Tuesday, July 29, 2014 |
| Status | 707 - PARTIAL SECTION 71 ACCEPTED |
| Status Date | Tuesday, May 17, 2022 |
| Registration Number | 4838850 |
| Registration Date | Tuesday, October 27, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 11, 2015 |
| Goods and Services | [Pharmaceutical and veterinary preparations for use in the treatment of cystic fibrosis, psychosomatic diseases, depression, epilepsy, endocrinologic disorders, cirrhoses, diseases associated with hormonal disturbances, autoimmune diseases, eye diseases, obesity, metabolic diseases, stroke, infectious diseases, cancer, degenerative diseases, neurodegenerative diseases, asthmatic diseases, dermatologic diseases, musculoskeletal diseases, periodontosis, dental diseases, diabetes, cardiovascular diseases, inflammatory diseases, hematologic diseases, urologic diseases or erectile dysfunctions, psychological diseases, broncholytic diseases, pulmonary diseases, dermatological diseases, lipid metabolism disorders, migraine, dementia, rheumatic disorders, gastric and intestinal diseases, enzyme deficiency and transport proteins disorders, analeptic diseases, anoretic diseases, blood diseases, allergic diseases, anemic diseases, geriatric diseases, cold and flu, hepatic diseases, immunological diseases, cardiac diseases, skeletal and muscle diseases, osteoporosis, ontological diseases, mouth and pharyngeal diseases, asthmatic diseases, bile-duct disorders, and arteriosclerosis; medical therapeutic agents for use in the treatment of cystic fibrosis, psychosomatic diseases, depression, epilepsy, endocrinologic disorders, cirrhoses, diseases associated with hormonal disturbances, autoimmune diseases, eye diseases, obesity, metabolic diseases, stroke, infectious diseases, cancer, degenerative diseases, neurodegenerative diseases, asthmatic diseases, dermatologic diseases, musculoskeletal diseases, periodontosis, dental diseases, diabetes, cardiovascular diseases, inflammatory diseases, hematologic diseases, urologic diseases or erectile dysfunctions, psychological diseases, broncholytic diseases, pulmonary diseases, dermatological diseases, lipid metabolism disorders, migraine, dementia, rheumatic disorders, gastric and intestinal diseases, enzyme deficiency and transport proteins disorders, analeptic diseases, anoretic diseases, blood diseases, allergic diseases, anemic diseases, geriatric diseases, cold and flu, hepatic diseases, immunological diseases, cardiac diseases, skeletal and muscle diseases, osteoporosis, ontological diseases, mouth and pharyngeal diseases, asthmatic diseases, bile-duct disorders, and arteriosclerosis; biochemical therapeutic agents for use in the treatment of cystic fibrosis, psychosomatic diseases, depression, epilepsy, endocrinologic disorders, cirrhoses, diseases associated with hormonal disturbances, autoimmune diseases, eye diseases, obesity, metabolic diseases, stroke, infectious diseases, cancer, degenerative diseases, neurodegenerative diseases, asthmatic diseases, dermatologic diseases, musculoskeletal diseases, periodontosis, dental diseases, diabetes, cardiovascular diseases, inflammatory diseases, hematologic diseases, urologic diseases or erectile dysfunctions, psychological diseases, broncholytic diseases, pulmonary diseases, dermatological diseases, lipid metabolism disorders, migraine, dementia, rheumatic disorders, gastric and intestinal diseases, enzyme deficiency and transport proteins disorders, analeptic diseases, anoretic diseases, blood diseases, allergic diseases, anemic diseases, geriatric diseases, cold and flu, hepatic diseases, immunological diseases, cardiac diseases, skeletal and muscle diseases, osteoporosis, ontological diseases, mouth and pharyngeal diseases, asthmatic diseases, bile-duct disorders, and arteriosclerosis, except preparations containing theophylline; diagnostic and analytical preparations for medical and veterinary use; biological and chemical diagnostic reagents for medical use] |
| Goods and Services | [Chemicals used in industry and science, in particular comprising antibody-like proteins or artificial proteins, except finishing agents for the preparation of synthetic and natural fibres; polypeptides and proteins for industrial purposes, including the manufacturing and purification of proteins, polypeptides, chemicals and other substances; diagnostic and analytic preparations for scientific or research use, not for medical or veterinary use; chemical reagents for analysis in laboratories, not for medical or veterinary use; biological tissue cultures for laboratories, not for medical or veterinary use; biological tissue cultures for laboratory analysis and diagnostics other than for medical or veterinary purposes] |
| Goods and Services | Scientific and industrial research in particular in the biological, biochemical, diagnostic and pharmaceutical fields; biochemistry and pharmaceutical laboratory services; scientific and technological services, namely, scientific research, analysis, testing, in particular in the biological, biochemical, diagnostic and pharmaceutical fields; industrial research and analysis, namely, services in development of biological, biochemical, pharmaceutical and diagnostic products; research for the identification and further development of biological, biochemical, pharmaceutical and diagnostic products |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Tuesday, May 17, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Tuesday, May 17, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 8, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Scil Proteins GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | Scil Proteins GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | Scil Proteins GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Monday, December 8, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 8, 2014 | ASSIGNED TO EXAMINER |
| Monday, December 8, 2014 | NON-FINAL ACTION WRITTEN |
| Saturday, December 27, 2014 | REFUSAL PROCESSED BY IB |
| Wednesday, June 10, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 17, 2015 | ASSIGNED TO LIE |
| Thursday, December 4, 2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, December 9, 2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 10, 2014 | REFUSAL PROCESSED BY MPU |
| Wednesday, December 10, 2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, December 12, 2014 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 24, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 24, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 6, 2015 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, July 6, 2015 | EXAMINERS AMENDMENT E-MAILED |
| Monday, July 6, 2015 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, July 6, 2015 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 7, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 8, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, August 5, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 5, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 27, 2016 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, May 12, 2016 | FINAL DISPOSITION PROCESSED |
| Thursday, May 12, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, July 22, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 11, 2015 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 11, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, August 21, 2015 | NOTIFICATION PROCESSED BY IB |
| Tuesday, October 27, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Friday, July 15, 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, October 27, 2020 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Tuesday, October 26, 2021 | TEAS SECTION 71 RECEIVED |
| Tuesday, May 10, 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, May 17, 2022 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
| Tuesday, January 17, 2023 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Tuesday, May 17, 2022 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Thursday, March 9, 2023 | INVALIDATION PROCESSED |
| Sunday, April 30, 2023 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Friday, May 24, 2024 | INTERNATIONAL REGISTRATION RENEWED |
| Thursday, March 9, 2023 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |